Das Klinikum

Dr. med. Selina Reiter

Dr. med. Selina Reiter

Ärztin in Weiterbildung

Kontakt

Telefonnummer: Pforte: 07071 29-84555

Klinik / Institut / Zentrum

  • Grünke T, Reiter S, Meyer S, Graf J, Schaeffeler N, Leiter U, Amaral T, Flatz L, Forschner A. Exploring 'decision regret' in adjuvant-treated melanoma patients: Results from a cross-sectional survey on 200 participants. J Eur Acad Dermatol Venereol. 2024 May 19. doi: 10.1111/jdv.20105. Epub ahead of print. PMID: 38764366.
  • Reiter, S., Schroeder, C., Broche, J., Sinnberg, T., Bonzheim, I., Süsskind, D., Flatz, L., & Forschner, A. (2023, April 19). Successful treatment of metastatic uveal melanoma with Ipilimumab and nivolumab after severe progression under tebentafusp: A case report. Frontiers. https://www.frontiersin.org/articles/10.3389/fonc.2023.1167791/full
  • Seitz CM, Mittelstaet J, Atar D, Hau J, Reiter S, Illi C, Kieble V, Engert F, Drees B, Bender G, Krahl AC, Knopf P, Schroeder S, Paulsen N, Rokhvarguer A, Scheuermann S, Rapp E, Mast AS, Rabsteyn A, Schleicher S, Grote S, Schilbach K, Kneilling M, Pichler B, Lock D, Kotter B, Dapa S, Miltenyi S, Kaiser A, Lang P, Handgretinger R, Schlegel P. Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting. Oncoimmunology. 2021 Dec 2;10(1):2003532. doi: 10.1080/2162402X.2021.2003532. PMID: 35686214; PMCID: PMC9172918
  • Seitz, C.M.; Kieble, C.V.; Illi, C.C.; Reiter, C.S.; Grote, M.S.; Mittelstaet, J.; Lock, M.D.; Kaiser, A.; Schleicher, S.; Handgretinger, R.; et al. Combinatorial Targeting of Multiple Shared Antigens By Adapter‐CAR‐T Cells (aCAR‐Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles. Blood 2018, 132, 4543, doi:10.1182/blood‐2018‐99‐115630